KRRO Korro Bio, Inc.
P/E
--
Forward P/E
--
Price/Sales
57.43
Beta
2.36
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Korro Bio Surges 10% on a Wall Street Upgrade, but Can RNA Editing Promises Survive the Long Road to Human Trials?
Shares of Korro Bio jumped 10.4% to $12.20 on June 18 after Jones Trading upgraded the stock from Hold to Buy, slapping a $23.00 price target that implies...
🟢 Korro Bio, Inc. is trading 10.36% up today after Jones Trading upgrade and positive RNA editing data
Korro Bio, Inc. is trading at $12.20 (+10.36%) today following a Jones Trading upgrade to Buy and reports of promising preclinical RNA editing data. • Jones...
🟢 Korro Bio, Inc. is trading 7.3% up today following analyst upgrade and promising preclinical data
Korro Bio, Inc. is trading at $11.85 (+7.27%) in pre-market. • Jones Trading upgraded Korro Bio to Buy with a price target of $23.00 after reporting promising...